Preexisting multimorbidity predicts greater mortality risks related to long-term PM2.5 exposure

Ziqing Tang1, Po-Wen Ku2, Yang Xia3

  • 1Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, China.

Insights

Long-term exposure to fine particulate matter (PM2.5) significantly increases mortality risks for individuals with multiple chronic conditions. This study reveals synergistic effects between PM2.5 and multimorbidity, highlighting heightened risks with more conditions and higher pollution levels.

Area of Science:

  • Environmental Health
  • Epidemiology
  • Public Health

Background:

  • Ambient fine particulate matter (PM2.5) exposure is a known health risk, but its impact on individuals with multimorbidity is understudied.
  • Both PM2.5 exposure and multimorbidity are independently associated with increased mortality.
  • The combined effects and interactions between PM2.5 and multimorbidity require further investigation.

Purpose of the Study:

  • To assess the associations between long-term PM2.5 exposure and all-cause, cardiovascular, and respiratory mortality in individuals with and without multimorbidity.
  • To examine the joint effects and interactions between PM2.5 exposure and multimorbidity on mortality risk.
  • To quantify the excess risks and attributable proportions of PM2.5-induced mortality in relation to multimorbidity status.

Main Methods:

  • A cross-cohort analysis of 3 prospective cohorts, enrolling 869,038 adults (aged ≥18 years) from 2005-2022.
  • Multimorbidity identified at baseline using nine common chronic conditions.
  • Cox proportional hazards models used to analyze associations, joint effects, and interactions, with stratified analyses by number of chronic conditions.

Main Results:

  • Among 713,119 eligible participants, 65,490 had prevalent multimorbidity.
  • PM2.5 exposure showed stronger associations with all-cause and cardiovascular mortality in individuals with multimorbidity compared to those without (P < 0.05 for heterogeneity).
  • Significant additive interaction observed: PM2.5 and multimorbidity synergistically increased mortality, with risks escalating with higher PM2.5 levels and more chronic conditions.

Conclusions:

  • Long-term PM2.5 exposure poses a significantly greater mortality risk to individuals with pre-existing multimorbidity.
  • Synergistic effects between PM2.5 exposure and multimorbidity intensify mortality risks, particularly in those with multiple chronic conditions.
  • Public health strategies should consider the heightened vulnerability of multimorbidity populations to air pollution.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205